In particular, Tsukada et al. [127] have shown that cognitive deficit induced by Aβ (1–42) in mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma (PPARγ) activation. This evidence concerns the gene PPARG and Cognitive impairment.